Sage Therapeutics, Inc. Quarterly Debt-to-equity in % from Q1 2015 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Sage Therapeutics, Inc. quarterly Debt-to-equity history and growth rate from Q1 2015 to Q3 2024.
  • Sage Therapeutics, Inc. Debt-to-equity for the quarter ending September 30, 2024 was 10.6 %, a 4.96% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 10.6 +0.5 +4.96% Sep 30, 2024
Q2 2024 11.8 +3.43 +41.2% Jun 30, 2024
Q1 2024 11.4 +3.87 +51.7% Mar 31, 2024
Q4 2023 10.8 +3.9 +57% Dec 31, 2023
Q3 2023 10.1 +3.88 +62.6% Sep 30, 2023
Q2 2023 8.32 +2.76 +49.6% Jun 30, 2023
Q1 2023 7.49 +2.41 +47.5% Mar 31, 2023
Q4 2022 6.85 +2.16 +46.1% Dec 31, 2022
Q3 2022 6.2 +1.84 +42.2% Sep 30, 2022
Q2 2022 5.56 +0.59 +11.9% Jun 30, 2022
Q1 2022 5.07 -1 -16.5% Mar 31, 2022
Q4 2021 4.68 -3.44 -42.3% Dec 31, 2021
Q3 2021 4.36 -8.29 -65.5% Sep 30, 2021
Q2 2021 4.97 -7.34 -59.6% Jun 30, 2021
Q1 2021 6.08 -5.46 -47.3% Mar 31, 2021
Q4 2020 8.13 -2.39 -22.7% Dec 31, 2020
Q3 2020 12.7 +3.06 +31.9% Sep 30, 2020
Q2 2020 12.3 +3.99 +47.9% Jun 30, 2020
Q1 2020 11.5 +4.4 +61.6% Mar 31, 2020
Q4 2019 10.5 +4.46 +73.7% Dec 31, 2019
Q3 2019 9.59 +3.87 +67.6% Sep 30, 2019
Q2 2019 8.33 +1.27 +18% Jun 30, 2019
Q1 2019 7.14 -1.88 -20.8% Mar 31, 2019
Q4 2018 6.05 -7.61 -55.7% Dec 31, 2018
Q3 2018 5.72 -7.6 -57% Sep 30, 2018
Q2 2018 7.06 -2.08 -22.8% Jun 30, 2018
Q1 2018 9.02 +0.94 +11.6% Mar 31, 2018
Q4 2017 13.7 +6.65 +94.9% Dec 31, 2017
Q3 2017 13.3 +6.94 +109% Sep 30, 2017
Q2 2017 9.14 +2.59 +39.5% Jun 30, 2017
Q1 2017 8.08 +2.07 +34.5% Mar 31, 2017
Q4 2016 7.01 +0.45 +6.86% Dec 31, 2016
Q3 2016 6.39 +0.47 +7.95% Sep 30, 2016
Q2 2016 6.55 +0.88 +15.5% Jun 30, 2016
Q1 2016 6.01 -2.13 -26.2% Mar 31, 2016
Q4 2015 6.56 Dec 31, 2015
Q3 2015 5.91 Sep 30, 2015
Q2 2015 5.67 Jun 30, 2015
Q1 2015 8.14 Mar 31, 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.